- Report
- October 2025
- 150 Pages
Global
From €2513EUR$2,850USD£2,207GBP
€3394EUR$3,850USD£2,981GBP
- Report
- July 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- January 2025
- 250 Pages
Global
From €4407EUR$4,999USD£3,871GBP
- Report
- July 2025
- 350 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- June 2025
- 150 Pages
Global
From €2379EUR$2,699USD£2,090GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Report
- June 2025
- 150 Pages
Global
From €2379EUR$2,699USD£2,090GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Report
- June 2025
- 150 Pages
Global
From €2379EUR$2,699USD£2,090GBP
- Report
- June 2025
- 150 Pages
Global
From €2379EUR$2,699USD£2,090GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Report
- June 2025
- 400 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- May 2025
- 300 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- June 2025
- 138 Pages
Global
From €3482EUR$3,950USD£3,059GBP
- Report
- January 2025
- 140 Pages
Global
From €3482EUR$3,950USD£3,059GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Report
- June 2025
- 400 Pages
Global
From €4363EUR$4,949USD£3,832GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more